Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IVERMECTIN vs IXEKIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IVERMECTIN vs IXEKIZUMAB: Safety Overview

Metric IVERMECTIN IXEKIZUMAB
Total FAERS Reports 3,018 33,680
Deaths Reported 221 470
Death Rate 7.3% 1.4%
Hospitalizations 600 2,424
Average Patient Age 53.3 yrs 52.0 yrs
% Female Patients 59.7% 60.2%
FDA Approval Date Apr 13, 2020 N/A
Manufacturer Asclemed USA, Inc. Eli Lilly and Company
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued Prescription